Definium Therapeutics, Inc. · NASDAQ:DFTX

Barrow Robert received 750,000 Definium Therapeutics, Inc. shares as an award (Form 4)

Traded Sep 14, 2026 · Filed Sep 14, 2026

On Sep 14, 2026, Barrow Robert (Director, Chief Executive Officer) received 750,000 Definium Therapeutics, Inc. shares as an award, leaving 2,244,640 shares. Filed Sep 14, 2026 (Form 4).

Awarded
750,000 shares
Holding after
2,244,640 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 14, 2026Common SharesAward750,0002,244,640Direct

Source

View original at SEC

Related